Novadiscovery
Angela Zubel is an accomplished medical professional currently serving as Chief Development Officer at Debiopharm International SA since February 2019. Prior experience includes leadership roles at Sandoz as Global Head Clinical Development Biopharmaceuticals and Clinical Development Unit Head in Oncology from February 2016 to February 2019, as well as serving as Clinical Program Leader for Oncology at Novartis Institutes for BioMedical Research (NIBR) from January 2011 to January 2016. Angela's career also encompasses a Medical Leader position in Oncology at the Healthcare Business of Merck from October 2004 to December 2010. Angela Zubel earned a Doctor of Medicine (MD) degree from Heidelberg University and pursued education at Jagiellonian University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Novadiscovery
novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enablingscientists and biotech, pharma companies to predict drug efficacy and create the target combination.